CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 29 enrolled / 29 target
Drug / intervention
MPC closed-loop system +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05799781
NCT05799781N/ACompletedOn Track (0.7/mo)Completion was 18mo ago

A Randomized Study to Compare a Fully-closed MPC Control Algorithm With a Commercial Hybrid Closed-loop Algorithm

Oregon Health and Science University·interventional·Posted Apr 5, 2023·Updated Jun 2, 2026

In Brief

A clinical study evaluating MPC closed-loop system and t:slim X2 pump with Dexcom G6 CGM and Control IQ for Type 1 Diabetes. Completed, enrolled 29 participants across 2 sites.

Detailed Summary

An artificial pancreas (AP) is a control system for automatic insulin delivery. The investigators have implemented a missed meal bolus detection algorithm for use within an AP control system. If a meal is detected that was not reported by the user, the system shall calculate the amount of meal insulin that will be dosed and deliver that insulin. The investigators will test how well the new algorithm manages glucose compared to the participant's usual care including the tslim X2 pump with Control IQ enabled. This type of algorithm may improve glucose control for high risk patient populations.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes
CountriesUnited States

Timeline

N/ACompletedFinished
202420252026
First PostedApr 5, 2023
Enrollment StartMar 13, 2023
Primary CompletionDec 27, 2024
Study CompletionJan 28, 2025
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 3.2 years ago

Arms & Interventions

MPC Armexperimental

Participants will use the MPC closed-loop system for 7 days using Fiasp insulin. The first 6 hours will be spent in clinic being trained on the system, then eating a meal. Then the participant will take the system home to continue using for 7 days.

Device: MPC closed-loop system
Control IQ armactive_comparator

Participants will continue their normal diabetes regimen which includes the t:slim X2 pump with Dexcom G6 CGM and Control IQ for 7 days. Participants will share their pump download and Dexcom Clarity data with study staff after the 7 days is complete.

Device: t:slim X2 pump with Dexcom G6 CGM and Control IQ

Interventions

MPC closed-loop systemdevice

The Model Predictive Control (MPC) insulin infusion algorithm contains a model within the controller that takes as an input the aerobic metabolic expenditure in addition to the CGM and meal in puts. The algorithm uses heart rate and accelerometer data collected on the patient's body to calculate metabolic expenditure (METs). The METs then acts on the model for the insulin dynamics, whereby more energy expenditure and longer duration exercise can lead to a more substantial effect of insulin on the CGM. The MPC also has missed meal insulin bolus detection where the system will calculate the amount of insulin that was missed for a meal. The missed meal boluses can be delivered automatically without any input from the user. This feature can also be disabled.

t:slim X2 pump with Dexcom G6 CGM and Control IQdevice

The t:slim pump is a hybrid closed-loop system available to consumers for automated insulin delivery. Control IQ technology automatically adjusts insulin levels based on continuous glucose monitoring (CGM) readings from Dexcom G6.